SCHEMBL4452422

SCHEMBL4452422

[CH2]C(O)(CC(C)(C)c1cccc(F)c1)C(F)(F)F

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 7/20 0.49
PGR P06401 2/20 0.49
NR3C2 P08235 3/20 0.41
CYP3A4 P08684 1/20 0.41
CYP19A1 P11511 2/20 0.39
KCNN4 O15554 4/20 0.39
MDM4 O15151 2/20 0.38
TP53 P04637 2/20 0.38
MDM2 Q00987 2/20 0.38
CHRM3 P20309 1/20 0.36
HDAC3 O15379 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
PTPN1 P18031 1/20 0.34
KIF11 P52732 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3658752 0.83 NR3C1 (0.34) NR3C1PGRNR3C2CHRM3
SCHEMBL4430202 0.82 TAAR1 (0.44) NR3C1PGRNR3C2CYP3A4
SCHEMBL4430210 0.81 PDK1 (0.43) NR3C2CYP3A4HDAC6KIF11
SCHEMBL14158802 0.79 L3MBTL1 (0.45) CYP3A4TP53
SCHEMBL3684124 0.78 CYP19A1 (0.36) NR3C1PGRNR3C2CYP3A4CYP19A1
SCHEMBL4437949 0.77 PTPN5 (0.41) CYP3A4
SCHEMBL3655647 0.76 NPY5R (0.43) NR3C1PGRNR3C2CYP3A4KIF11
SCHEMBL4448695 0.76 HTR2A (0.34) NR3C1PGRNR3C2
SCHEMBL291662 0.74 NR3C1 (0.57) NR3C1PGRNR3C2CYP3A4
SCHEMBL3679775 0.74 NPSR1 (0.37) NR3C1PGRNR3C2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2051736-A2 COMPOSITIONS COMPRISING A DISSOCIATED GLUCOCORTICOID RECEPTOR AGONIST AND AN IMMUNOSUPPRESSIVE AGENT FOR TREATING DRY EYE Bausch & Lomb Incorporated (US) 2009-04-29 EP disclosed
WO-2008005686-A2 COMPOSITIONS COMPRISING A DISSOCIATED GLUCOCORTICOID RECEPTOR AGONIST AND AN IMMUNOSUPPRESSIVE AGENT FOR TREATING DRY EYE BAUSCH & LOMB INCORPORATED (US) 2008-01-10 WO disclosed